スプリット・アンド・ミックス・リポソーム・プロテオリシス・ターゲティング・キメラ・アプローチによる興味のあるタンパク質の分解
Chunli Song1, Zijun Jiao2,3, Zhanfeng Hou1
1State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China.
Journal of the American Chemical Society
|September 14, 2023
まとめ
この研究では,リポソームベースの分割・混合型タンパク質分解ターゲティングキメラ (PROTAC) システムが導入されています. この新しいLipoSM- PROTACは,低濃度で腫瘍を標的とし,タンパク質を分解する効果を高めています.
科学分野:
- バイオテクノロジー
- 分子生物学
- 薬物投与システム
背景:
- プロテオリシス・ターゲティング・キメラ (PROTAC) 技術は,標的型タンパク質の分解のためにユビキチン-プロテアソームシステムを利用します.
- 以前のペプチドベースの分割および混合PROTACs (SM- PROTACs) は有望であったが,薬剤の有効性により制限された.
- 標的型投与と有効性の向上は,バイオメディカルアプリケーションにおけるPROTAC技術の進歩に不可欠です.
研究 の 目的:
- リポソームの自己組み立てによる新しい分割・混合PROTAC (LipoSM-PROTAC) システムを開発する.
- 葉酸 (FA) 改変を用いて腫瘍を標的とする能力を強化する.
- エストロゲン受容体アルファ (ERα) の退廃に対するLipoSM- PROTACの有効性を検証する.
主な方法:
- PROTACを分割して混合するための脂質体自己組み立てナノプラットフォームの構築.
- 腫瘍細胞の標的化を強化するために,ナノプラットフォームを葉酸 (FA) で修正する.
- 葉酸受容体陽性 (FR+) 細胞におけるERα分解のインビトロ検証
主要な成果:
- LipoSM- PROTACシステムは,FR+細胞で効率的かつ選択的な吸収を示した.
- 標的タンパク質ERαの有意な分解は,低濃度で達成された.
- ペプチドベースのSM- PROTACと比較して,LipoSM- PROTACはより低い用量での優れた治療効果を示しました.
結論:
- 開発されたLipoSM-PROTACシステムは 薬剤の効能と腫瘍を標的とする能力を向上させています
- このリポソームベースのプラットフォームは,PROTAC技術における臨床翻訳に重要な可能性を秘めています.
- LipoSMプラットフォームは,PROTACの開発と他のバイオ分子規制のための汎用的なアプローチを提供します.
関連する概念動画
The Proteasome
10.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.6K
Regulated Protein Degradation
9.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Intralumenal Vesicles and Multivesicular Bodies
5.2K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.2K
Tagging and Fusion Proteins
8.7K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.7K
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome Structure
2.2K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
2.2K


